BIPHENTIN 50 MG
METHYLPHENIDATE HYDROCHLORIDE : 50 MG · DIN 02277190 · ELVIUM LIFE SCIENCES
Health Canada status: MARKETED
What is BIPHENTIN?
BIPHENTIN 50 MG contains METHYLPHENIDATE HYDROCHLORIDE : 50 MG. It is listed in the Health Canada Drug Product Database under DIN 02277190, held by ELVIUM LIFE SCIENCES, supplied as CAPSULE (EXTENDED RELEASE) for ORAL administration. Health Canada currently lists it as marketed, status dated 03-Sep-2020. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is BIPHENTIN used for?
BIPHENTIN® (methylphenidate hydrochloride controlled-release capsules) is indicated for the treatment of Attention-Deficit Hyperactivity Disorder (ADHD) in: Children (6 - 11 years of age), Adolescents (12 - 18 years of age), Adults (>18 years of age).
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02277190 |
|---|---|
| Brand name | BIPHENTIN |
| Generic / active ingredient | METHYLPHENIDATE HYDROCHLORIDE : 50 MG |
| Manufacturer | ELVIUM LIFE SCIENCES |
| Strength | 50 MG |
| Dosage form | CAPSULE (EXTENDED RELEASE) |
| Route of administration | ORAL |
| Schedule | CONTROLLED DRUGS (CDSA III) |
| ATC code | N06BA04 METHYLPHENIDATE |
| AHFS class | 28:20.32 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 03-Sep-2020 |
| Original market date | 2006-08-01 00:00:00 |
How is it stored and handled?
null
How is it supplied?
opaque plastic bottles of 100 capsules for 10, 15, 20, 30, and 40 mg strengths. opaque plastic bottles of 50 capsules for 50, 60 and 80 mg strengths.
What can be used instead?
Other Canadian products sharing ATC code N06BA04 METHYLPHENIDATE. 55 of 103 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ACT METHYLPHENIDATE ER | 18 MG | TABLET (EXTENDED-RELEASE) | TEVA CANADA LIMITED | MARKETED | DIN 02441934 |
| ACT METHYLPHENIDATE ER | 27 MG | TABLET (EXTENDED-RELEASE) | TEVA CANADA LIMITED | MARKETED | DIN 02441942 |
| ACT METHYLPHENIDATE ER | 36 MG | TABLET (EXTENDED-RELEASE) | TEVA CANADA LIMITED | MARKETED | DIN 02441950 |
| ACT METHYLPHENIDATE ER | 54 MG | TABLET (EXTENDED-RELEASE) | TEVA CANADA LIMITED | MARKETED | DIN 02441969 |
| APO-METHYLPHENIDATE | 10 MG | TABLET | APOTEX INC | MARKETED | DIN 02249324 |
| APO-METHYLPHENIDATE | 20 MG | TABLET | APOTEX INC | MARKETED | DIN 02249332 |
| APO-METHYLPHENIDATE | 5 MG | TABLET | APOTEX INC | MARKETED | DIN 02273950 |
| APO-METHYLPHENIDATE ER | 18 MG | TABLET (EXTENDED-RELEASE) | APOTEX INC | MARKETED | DIN 02452731 |
| APO-METHYLPHENIDATE ER | 27 MG | TABLET (EXTENDED-RELEASE) | APOTEX INC | MARKETED | DIN 02452758 |
| APO-METHYLPHENIDATE ER | 36 MG | TABLET (EXTENDED-RELEASE) | APOTEX INC | MARKETED | DIN 02452766 |
Who else supplies METHYLPHENIDATE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. METHYLPHENIDATE appears in 923 registered pack listings across 8 markets, published on 7 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.